Project Grant R43HL152835

This $437,461 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a novel stabilization catheter device for His pacing lead implantation. The goal is to improve the accuracy and ease of His bundle pacing, an emerging alternative cardiac resynchronization therapy (CRT) for heart failure patients. The project aims to refine a deployable suction-tipped lead...

This Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, provides $920,176 under the Cardiovascular Diseases Research program to develop a smart aspiration catheter with fiber optic pressure sensors for mechanical thrombectomy procedures to treat acute ischemic stroke. The catheter will be designed, prototyped and validated at Worcester Polytechnic Institute to provide real-time data to interventionalists on the interaction...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $413,595 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Unandup, LLC, a St. Louis-based technology development firm, to fund the development of a Magnetic Rotational Platform for Coronary Lesions. The project aims to address the significant clinical challenges associated with percutaneous coronary intervention (PCI) procedures, particularly in navigating tortuous vessels and enabling stent...

The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $395,306 project grant to Cutcath LLC on July 15, 2025. The grant supports the development and evaluation of the Cutcath Dissection Septum Cutting Catheter (DSCC), a novel minimally invasive device designed to facilitate effective landing zones for thoracic endovascular aortic repair (TEVAR) or endovascular aneurysm repair (EVAR) procedures in patients with acute...

Corveus Medical, Inc. was awarded a $255,841 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an extravascular bipolar catheter for targeted nerve ablation with minimal collateral damage to surrounding tissues. The grant aims to support the design and prototyping of a minimally invasive, catheter-delivered venous procedure for performing extravascular greater splanchnic nerve ablation. The proposed catheter...

Percassist Inc. received a $663,129 Project Grant award from the National Heart Lung and Blood Institute of the Department of Health and Human Services. The award was made under the Cardiovascular Diseases Research program (CFDA 93.837), which supports heart and vascular research. The grant funds the development of a percutaneous ventricular assist device for chronic heart failure patients. Specifically, Percassist will design and test a balloon catheter implant that can be delivered minimally...

This $256,000 National Science Foundation project grant supports the development of an automated chest tube to prevent clotting. Circulatech LLC will design and prototype a novel chest tube that proactively manages fluid flow within the catheter lumen to flush and drain the tube, reducing blood clot formation. Through a process called "dilutional coagulopathy," the tube will use sterile saline or anticoagulants to reduce thrombosis in the drainage space rather than relying on...

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $366,006 Project Grant (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) to the Georgia Tech Research Corporation to develop flexible piezo film intravascular ultrasound (IVUS) arrays on guidewires and catheters. The goal is to integrate IVUS imaging capability onto standard guidewires and catheters used in over 1 million percutaneous coronary and peripheral...

This $313,302 Project Grant was awarded by the National Heart, Lung, and Blood Institute, under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), to support the development of a novel lead delivery platform for Cardiac Conduction System (CCS) pacing. The project aims to create a 3D pre-shaped delivery catheter with features to enable physicians to precisely identify and safely deliver CCS pacing leads, with the goal of improving upon existing CCS pacing techniques like...

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $306,463 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Dogpatch Medical LLC, located in California. The grant, awarded on September 1, 2025, will support the development of PassiveCath, an innovative microcatheter device designed to enhance the visibility and delivery of drugs to the central nervous system. PassiveCath leverages...